Securing Cell-Free Expression: Safeguards for Distributed Biomanufacturing

Cell-free expression (CFE) is an acellular biomanufacturing platform capable of producing diverse biomolecules, including proteins, enzymes, and mRNA, outside of living cells. Unlike traditional bioproduction, which requires sterile culture systems and large-scale bioreactors, CFE enables rapid, modular, and decentralized synthesis. CFE extracts can be freeze-dried, stored for extended periods, and reactivated on demand by simply adding a nucleic acid template. This makes it particularly suited for point-of-need applications such as diagnostics, vaccines, and potentially therapeutics in remote, resource-limited, or emergency settings. However, the same features introduce novel biosecurity concerns. Commercially available CFE kits already support the production of bacteriophages and virus-like particles with minimal specialized equipment. As benchtop DNA synthesis and CFE technologies become increasingly accessible, barriers of skill, facilities, and resources are significantly reduced, enabling malicious actors or small autonomous groups to generate harmful biological agents. To address these risks while enabling safe deployment, we recommend: (1) investing in yield optimization and the development of modular, good manufacturing practice-compatible CFE units for distributed manufacturing (performance and scalability); (2) engineering CFE systems with bioorthogonal or otherwise nontransferable components to reduce potential misuse (intrinsic safety feature); and (3) implementing risk-based restrictions for different CFE formulations, balancing innovation with security oversight (tiered access controls). By combining these measures, CFE can be responsibly integrated into global health security infrastructure, delivering its transformative benefits without compromising biosecurity.

Authors

Institutions

Publication Details

Journal
Health Security
Published
2026-11-17
DOI
https://doi.org/10.1177/23265094261499980
Primary Topic
Global Security and Public Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Securing Cell-Free Expression: Safeguards for Distributed Biomanufacturing

Sriharshita Musunuri, Liyam Chitayat
1 links
Health Security
Global Security and Public Health
article

Securing Cell-Free Expression: Safeguards for Distributed Biomanufacturing

Sriharshita Musunuri, Liyam Chitayat
article en

Abstract

Cell-free expression (CFE) is an acellular biomanufacturing platform capable of producing diverse biomolecules, including proteins, enzymes, and mRNA, outside of living cells. Unlike traditional bioproduction, which requires sterile culture systems and large-scale bioreactors, CFE enables rapid, modular, and decentralized synthesis. CFE extracts can be freeze-dried, stored for extended periods, and reactivated on demand by simply adding a nucleic acid template. This makes it particularly suited for point-of-need applications such as diagnostics, vaccines, and potentially therapeutics in remote, resource-limited, or emergency settings. However, the same features introduce novel biosecurity concerns. Commercially available CFE kits already support the production of bacteriophages and virus-like particles with minimal specialized equipment. As benchtop DNA synthesis and CFE technologies become increasingly accessible, barriers of skill, facilities, and resources are significantly reduced, enabling malicious actors or small autonomous groups to generate harmful biological agents. To address these risks while enabling safe deployment, we recommend: (1) investing in yield optimization and the development of modular, good manufacturing practice-compatible CFE units for distributed manufacturing (performance and scalability); (2) engineering CFE systems with bioorthogonal or otherwise nontransferable components to reduce potential misuse (intrinsic safety feature); and (3) implementing risk-based restrictions for different CFE formulations, balancing innovation with security oversight (tiered access controls). By combining these measures, CFE can be responsibly integrated into global health security infrastructure, delivering its transformative benefits without compromising biosecurity.

Health Security
Gladstone Institutes (US), University of California, San Francisco (US), Massachusetts Institute of Technology (US)
Good health and well-being, Industry, innovation and infrastructure
Global Security and Public Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon